Tag: Top-Line Revenue Forecast

news-19102024-150949

Tevogen Bio Oncology Forecasts $1B in Launch Year Revenue, $10-14B in 5 Years; Expansion...

Tevogen Bio, a biotech company focused on developing immunotherapy treatments for infectious diseases and cancers, has made a bold prediction regarding its oncology pipeline....